Northwest Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Northwest Wealth Management's ABBV Position: Q3 2026 in Review
Northwest Wealth Management increased its AbbVie (ABBV) stake by 0.89% in Q3 2026, buying an estimated $4.1K and bringing the position to 1,819 shares worth $476K. The position accounts for 0.06% of the portfolio, ranked #134.
Northwest Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 25 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Northwest Wealth Management held 1,819 shares of AbbVie worth $476K as of Q3 2026.
- Northwest Wealth Management bought 16 AbbVie shares in Q3 2026, an estimated $4.1K.
- AbbVie made up 0.06% of Northwest Wealth Management's portfolio in Q3 2026, its #134 holding.
- Northwest Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 25 quarters since.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Northwest Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.